Quanome Technologies/$QNME
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Quanome Technologies
Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis.
- Ticker
- $QNME
- Sector
- Mobility
- Primary listing
- NASDAQ
- Employees
- 27
- Headquarters
- New York, United States
- Website
- quanometech.com
QNME Metrics
BasicAdvanced
$12M
-
-$0.37
1.86
-
Price and volume
Market cap
$12M
Beta
1.86
52-week high
$1.40
52-week low
$0.25
Average daily volume
4.6M
Financial strength
Current ratio
2.456
Quick ratio
0.403
Long term debt to equity
0.023
Total debt to equity
0.1
Interest coverage (TTM)
-49.00%
Profitability
EBITDA (TTM)
-7.195
Gross margin (TTM)
17.93%
Net profit margin (TTM)
-162.10%
Operating margin (TTM)
-125.33%
Effective tax rate (TTM)
-0.91%
Revenue per employee (TTM)
$220,000
Management effectiveness
Return on assets (TTM)
-35.17%
Return on equity (TTM)
-205.82%
Valuation
Price to revenue (TTM)
1.503
Price to book
1.68
Price to tangible book (TTM)
1.75
Price to free cash flow (TTM)
-1.856
Free cash flow yield (TTM)
-53.88%
Free cash flow per share (TTM)
-0.184
Growth
Revenue change (TTM)
111.79%
Earnings per share change (TTM)
-46.88%
3-year revenue growth (CAGR)
-23.11%
3-year earnings per share growth (CAGR)
31.03%
QNME Financial Performance
Revenues and expenses
Upcoming events
No upcoming events
QNME News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.